Stryker Corporation reported $25.8B of revenue over the trailing twelve months, +8.5% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $25.8B (to Q2 2026). Net income: $3.73B, trailing twelve months to Q2 2026. Free cash flow: $4.70B, trailing twelve months to Q2 2026. Operating margin: 21%, trailing twelve months to Q2 2026.

SYKStryker Corporation

Healthcare

$277.28-26% 1Y

$277.28

$269.8652 weeks$386.41

SYK as reported

Stryker Corporation reported $25.8B of revenue over the trailing twelve months, +8.5% on the year before. 11 reported series are charted on this page, each one as filed.

$25.8B

Revenue, trailing twelve months · to Q2 2026 · +8.5% against the twelve months before

Net income: $3.73B
Net income · +28% year on year · trailing twelve months to Q2 2026
Free cash flow: $4.70B
Free cash flow · +17% year on year · trailing twelve months to Q2 2026
Operating margin: 21%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for SYK, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$25.8B	+8.5%	Q2 2026
Net income	$3.73B	+28%	Q2 2026
EPS	$9.65	+28%	Q2 2026
Gross margin	65%	n/a	Q2 2026
Operating margin	21%	n/a	Q2 2026
Net margin	14%	n/a	Q2 2026
ROE	15%	n/a	Q2 2026
ROA	7.0%	n/a	Q2 2026
ROIC	11%	n/a	Q2 2026
Free cash flow	$4.70B	+17%	Q2 2026
P/E	28.7	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.